<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
FILED PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934 AND RULE 13A-17 OR 15D-17 THEREUNDER
ABIOMED, Inc.
-------------
(Exact name of issuer as specified in charter)
33 Cherry Hill Drive, Danvers, Massachusetts 01923
---------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code (508) 777-5410
--------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding:
1. Title of security Common Stock
--------------------------------------------------------
2. Number of shares outstanding before the change : 4,891,202
---------
3. Number of shares outstanding after the change: 5,503,202
----------
4. Effective date of change: August 10, 1995
----------------
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution,
stock split, reverse split, acquisition of stock for treasury, etc.)
Conversion of Class A Common Stock
-------------------------------------------------------------------------
Give brief description of transaction Shares are being issued in connection
-------------------------------------
with the conversion of 612,000 Shares of Class A Common Stock into an equal
- --------------------------------------------------------------------------------
number of shares of Common Stock.
- --------------------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
----------------------------
1. Name prior to change
--------------------------------------------------------
2. Name after change
-----------------------------------------------------------
3. Effective date of charter amendment changing name
---------------------------
4. Date of shareholder approval of change, if required
-------------------------
Date: August 11, 1995 /s/ John F. Thero
--------------- -------------------------------
John F. Thero
Vice President Finance and Administration
Chief Financial Officer
